Prescription Songs has inked a deal with Nashville-based producer and songwriter JT Daly. He will be represented by Katie Fagan, Prescription Songs Head of A&R, Nashville, alongside Rachel Wein and Chris Martignago.
Daly has garnered Grammy nominations for Best Rock Song and Best Engineered Album for producing/co-writing K. Flay‘s “Blood in the Cut” and more on her breakout album Everywhere is Somewhere. In winter 2021, JT produced and co-wrote Benson Boone’s debut single “Ghost Town,” which has already accumulated over 100 million streams.
He has also collaborated with PVRIS on her newest track “Snakes” for the top Netflix series Arcane. Other previous releases include collaborations with Grandson, Bren Joy and Quinn XCII. Upcoming releases include work with Why Don’t We, The Regrettes, and Fleurie.
Fagan comments: “JT is an extremely innovative songwriter, producer and artist. We feel incredibly honored and lucky to have such a talent as a part of our roster, especially here in Nashville. There’s a reason that artists continually want him to be a part of their journeys. I can’t wait to see what we will be able to accomplish together.”
“It is with an abundance of joy that I have found a team this hands-on and talented. After a few conversations with Katie Fagan I felt more at home than I ever have before,” shares Daly. “She puts in the time needed to know her writers. Something I will never take for granted.”
Prescription Songs is an independent publisher representing top songwriters and producers across all genres of music. Its current and past roster includes Grammy award-winners and nominees, multiple recipients of ASCAP and BMI Songwriter of the Year Awards, a winner of the 2020 VMA Push New Artist Award, iHeartRadio Producer of the Year, and more.
- Nate Smith Nabs First Chart-Topper With Debut Single, ‘Whiskey On You’ - January 30, 2023
- Ross Copperman Makes His Way Into The Top Five On MusicRow Top Songwriter Chart - January 30, 2023
- Weekly Register: Hardy Makes Massive Debuts On Country Albums & Songs Charts - January 30, 2023